Pharmacokinetics and Systemic Activity of a New Patent of an Inhaled Corticosteroid/Long-Acting β2-Agonist Combination for Use in Asthma Therapy: Fluticasone Furoate/Vilanterol Trifenatate.

Wolthers, Ole D

Pharmacokinetics and Systemic Activity of a New Patent of an Inhaled Corticosteroid/Long-Acting β2-Agonist Combination for Use in Asthma Therapy: Fluticasone Furoate/Vilanterol Trifenatate. [electronic resource] - Recent patents on inflammation & allergy drug discovery 2015 - 144-50 p. digital

Publication Type: Journal Article; Review

1872-213X

10.2174/1872213x10666151119144907 doi


Administration, Inhalation
Administration, Oral
Adrenal Cortex Hormones--administration & dosage
Adrenergic beta-2 Receptor Agonists--administration & dosage
Age Factors
Androstadienes--administration & dosage
Animals
Anti-Asthmatic Agents--administration & dosage
Asthma--drug therapy
Benzyl Alcohols--administration & dosage
Biological Availability
Bronchoconstriction--drug effects
Bronchodilator Agents--administration & dosage
Chlorobenzenes--administration & dosage
Drug Administration Schedule
Drug Combinations
Drug and Narcotic Control
Humans
Lung--drug effects
Patents as Topic
Risk Factors
Treatment Outcome